CSIMarket
 


Can fite Biopharma Ltd   (CANF)
Other Ticker:  
 

Cumulative Can Fite Biopharma Ltd 's Quick Ratio for Trailing Twelve Months Period

CANF's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

CANF Quick Ratio for Trailing Twelve Months Period

(Dec 31 2022)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2021)
IV. Quarter
Y / Y Current Liabilities Growth -6.54 % -6.54 % -6.54 % -6.54 % 118.35 %
Y / Y Cash & cash equivalent Growth -58.27 % -58.27 % -58.27 % -58.27 % 129.4 %
Quick Ratio for Trailing Twelve Months Period 3.19 4.23 5.24 6.21 7.15
Total Ranking # 991 # 839 # 826 # 761 # 669
Seq. Current Liabilities Growth 0 % 0 % 0 % -6.54 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % -58.27 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Dec 31 2022
On the trailing twelve months basis Despite year on year decrease in Can Fite Biopharma Ltd 's average Current Liabilities to $3 millions, Quick Ratio for Trailing Twelve Months Period to 3.19 below company average Quick Ratio for Trailing Twelve Months Period.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 324 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Can Fite Biopharma Ltd . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about CANF
Quick Ratio CANF in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 325
Sector # 563
S&P 500 # 972


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
7.01 3.88 0.82
(Dec 31 2021)   (Dec 31 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2022, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Indaptus Therapeutics Inc   8.76 
Sunshine Biopharma Inc   8.59 
Phathom Pharmaceuticals Inc   8.48 
Hoth Therapeutics Inc   8.47 
Tonix Pharmaceuticals Holding Corp   8.45 
Rhythm Pharmaceuticals inc   8.37 
Sinovac Biotech Ltd  8.33 
Mustang Bio inc   8.25 
Bolt Biotherapeutics Inc   8.16 
Ocuphire Pharma Inc   8.05 
Gain Therapeutics inc  8.01 
Aileron Therapeutics Inc   8.00 
Bright Minds Biosciences Inc   7.97 
Carisma Therapeutics Inc   7.90 
Ionis Pharmaceuticals Inc  7.88 
Monopar Therapeutics Inc   7.88 
Immunic Inc   7.83 
Connect Biopharma Holdings Limited  7.78 
Atreca inc   7.76 
Marinus Pharmaceuticals Inc   7.75 
Aeterna Zentaris Inc   7.74 
Gracell Biotechnologies Inc   7.66 
Werewolf Therapeutics Inc   7.64 
Zai Lab Limited  7.54 
Rain Oncology Inc   7.53 
Ideaya Biosciences Inc   7.51 
Vera Therapeutics Inc   7.49 
Zentalis Pharmaceuticals Inc   7.45 
Enveric Biosciences Inc   7.41 
Global Blood Therapeutics Inc.  7.40 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com